Schönhöfer is a professor, pharmacologist, and has been a critic of the corrupt practices of some pharmaceutical companies for more than two decades. Schönhöfer would have had to pay the damages out of his own pocket, but in the end he always came out on top in court. Putting profits above patients has dire effects, the professor warns. "We can observe roughly a 150-fold increase in the costs of chemotherapy in solid cancers over the past 30 years, but no significant gain in average life expectancy of more than a single week," he explains. "It is necessary to uncover these corrupting structures and strategies in order to keep our health care systems functioning." Schönhöfer is not about to rest on his laurels. He is willing to risk it all again if that is the price for speaking the truth.